O BSH shows whose priority will be to be vaccinated by Ovid-19

The head of the World Health Organization, Tedros Adhanom Ghebrreesus, said on Saturday that people most vulnerable to the virus must be the first to have access to the vaccine against Avid-19. The organization he runs will grant approval for the vaccine against Corona-virus, only when proven to be safe [...]
The organization he runs will provide approval for the vaccine against Corona-virus, only when proven to be safe, adding that medical workers who fight the first line against this virus must be the first to have access to the vaccine, in the early stages of its production, when and the amount will be limited.
O Leader Declaration The BSH comes after the chairman of WHO's scientific group, Sounju Suminthan, announced that vaccine against COVID-19, will be ready only in the second half of 2021.
The “is an optimistic scenario as we have many candidates working on the development of the vaccine. We expect results from some of them who are in the phase of developing final tests. We think that by the end of this year or early next year, the production of millions of doses of vaccine against Covid-19 will begin, and if everything goes well in the middle of next year, we believe that people will have access to medicine”, said Soumya Suminathan, chief of the scientific team in WHO
WHO leader agrees that the moment the vaccine against Ovidius-19 begins to be produced, its distribution should become proportionally between the ages and the most vulnerable and not just for countries that have economic opportunities to get it
When we have an effective vaccine, we should use it properly. As time goes by and its production increases, we need to think that everyone around the globe will have access to the vaccine, but first when production is limited, we have to prioritize the vaccine of medical personnel and those most vulnerable to the virus, including the third age and persons suffering from accompanying”, said Tedros Adhanhabresus, director of WHO.
Hundreds of vaccines are being tested at the global level, but so far there is still no final result, since more time is needed for the study of all effects.











